EP1259223A4 - Protein matrix materials, devices and methods of making and using thereof - Google Patents

Protein matrix materials, devices and methods of making and using thereof

Info

Publication number
EP1259223A4
EP1259223A4 EP01922258A EP01922258A EP1259223A4 EP 1259223 A4 EP1259223 A4 EP 1259223A4 EP 01922258 A EP01922258 A EP 01922258A EP 01922258 A EP01922258 A EP 01922258A EP 1259223 A4 EP1259223 A4 EP 1259223A4
Authority
EP
European Patent Office
Prior art keywords
making
methods
devices
matrix materials
protein matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP01922258A
Other languages
German (de)
French (fr)
Other versions
EP1259223A1 (en
Inventor
David B Masters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gel Del Technologies Inc
Original Assignee
Gel Del Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gel Del Technologies Inc filed Critical Gel Del Technologies Inc
Publication of EP1259223A1 publication Critical patent/EP1259223A1/en
Publication of EP1259223A4 publication Critical patent/EP1259223A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
EP01922258A 2000-02-28 2001-02-28 Protein matrix materials, devices and methods of making and using thereof Ceased EP1259223A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18542000P 2000-02-28 2000-02-28
US185420P 2000-02-28
US22276200P 2000-08-03 2000-08-03
US222762P 2000-08-03
PCT/US2001/006502 WO2001087267A1 (en) 2000-02-28 2001-02-28 Protein matrix materials, devices and methods of making and using thereof

Publications (2)

Publication Number Publication Date
EP1259223A1 EP1259223A1 (en) 2002-11-27
EP1259223A4 true EP1259223A4 (en) 2006-11-29

Family

ID=26881122

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01922258A Ceased EP1259223A4 (en) 2000-02-28 2001-02-28 Protein matrix materials, devices and methods of making and using thereof

Country Status (5)

Country Link
EP (1) EP1259223A4 (en)
JP (1) JP2003533468A (en)
AU (2) AU4907901A (en)
CA (1) CA2401385C (en)
WO (1) WO2001087267A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108310455A (en) * 2018-03-20 2018-07-24 嘉兴尔云信息科技有限公司 Nanometer hydroxyapatite, phosphorylation polyester composite bone repairing material and preparation method thereof

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890546B2 (en) 1998-09-24 2005-05-10 Abbott Laboratories Medical devices containing rapamycin analogs
US20030007991A1 (en) * 1998-09-25 2003-01-09 Masters David B. Devices including protein matrix materials and methods of making and using thereof
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US20050147690A1 (en) * 1998-09-25 2005-07-07 Masters David B. Biocompatible protein particles, particle devices and methods thereof
US20020156437A1 (en) * 2000-12-22 2002-10-24 Kimberly-Clark Worldwide, Inc. Removal of targeted proteases with proteinaceous wound dressings containing growth factors
US6444222B1 (en) * 2001-05-08 2002-09-03 Verigen Transplantation Services International Ag Reinforced matrices
DE60204158T2 (en) 2001-10-05 2006-02-02 SurModics, Inc., Eden Prairie COATINGS WITH IMMOBILIZED PARTICLES AND USES THEREOF
US6902932B2 (en) * 2001-11-16 2005-06-07 Tissue Regeneration, Inc. Helically organized silk fibroin fiber bundles for matrices in tissue engineering
JP2005512735A (en) * 2001-12-21 2005-05-12 コロプラスト アクティーゼルスカブ Wound care device
WO2003092468A2 (en) 2002-04-29 2003-11-13 Gel-Del Technologies, Inc. Biomatrix structural containment and fixation systems and methods of use thereof
JP2006500975A (en) * 2002-08-02 2006-01-12 ジーピー メディカル Drug-carrying biomaterials chemically treated with genipin
WO2004034975A2 (en) * 2002-10-17 2004-04-29 Alkermes Controlled Therapeutics, Inc. Sustained release profile modification
JP2006505364A (en) * 2002-11-08 2006-02-16 コナー　メドシステムズ，　インコーポレイテッド Expandable medical device and method for treating chronic total infarction using a local supply of angiogenic factors
DE602004024834D1 (en) * 2003-03-28 2010-02-04 Fuji Film Mfg Europ B V RGD-enriched, gelatin-like proteins to prevent cell adhesion
JP4850709B2 (en) * 2003-05-14 2012-01-11 ダニスコ・ユーエス・インコーポレーテッド Controlled release of active agent using repetitive sequence protein polymer
US8465537B2 (en) 2003-06-17 2013-06-18 Gel-Del Technologies, Inc. Encapsulated or coated stent systems
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
EP1660013A4 (en) 2003-08-26 2011-07-20 Gel Del Technologies Inc Protein biomaterials and biocoacervates and methods of making and using thereof
CA2548822C (en) 2003-12-08 2015-08-11 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
WO2005072223A2 (en) 2004-01-23 2005-08-11 California Institute Of Technology Engineered proteins, and methods of making and using
WO2005123114A2 (en) 2004-06-11 2005-12-29 Trustees Of Tufts College Silk-based drug delivery system
US20060067971A1 (en) * 2004-09-27 2006-03-30 Story Brooks J Bone void filler
WO2007100524A2 (en) * 2006-02-23 2007-09-07 Genencor International, Inc. Repeat sequence protein polymer nanoparticles optionally containing active agents and their preparation
US8267918B2 (en) * 2006-03-14 2012-09-18 Kci Licensing, Inc. System and method for percutaneously administering reduced pressure treatment using a flowable manifold
AU2008345047A1 (en) 2007-12-26 2009-07-09 Gel-Del Technologies, Inc. Biocompatible protein particles, particle devices and methods thereof
CN101221180B (en) * 2008-01-25 2011-11-30 马义才 Portable fast joint inspection device for multiple tumor marker
WO2010026760A1 (en) * 2008-09-03 2010-03-11 富士フイルム株式会社 Compositions wherein bioactive components are stably sealed
WO2010057177A2 (en) 2008-11-17 2010-05-20 Gel-Del Technologies, Inc. Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
US9308070B2 (en) 2008-12-15 2016-04-12 Allergan, Inc. Pliable silk medical device
US20110060419A1 (en) * 2009-03-27 2011-03-10 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
EP2435102B1 (en) 2009-05-28 2020-07-15 AddBIO AB Multilayer protein films, methods of making, and drug delivery devices and biomedical implants employing the films
CN104203292B (en) * 2011-11-09 2019-05-31 塔夫茨大学信托人 Injectable silk fibroin foam and application thereof
CA2867464A1 (en) * 2012-03-20 2013-09-26 Trustees Of Tufts College Silk reservoirs for drug delivery
US9546128B2 (en) 2012-03-29 2017-01-17 Shire Human Genetic Therapies, Inc. Ionizable cationic lipids
US8691915B2 (en) 2012-04-23 2014-04-08 Sabic Innovative Plastics Ip B.V. Copolymers and polymer blends having improved refractive indices
US11617815B2 (en) 2016-10-31 2023-04-04 Sofregen Medical, Inc. Compositions comprising silk fibroin particles and uses thereof
CN108926744A (en) * 2018-09-13 2018-12-04 广州贝奥吉因生物科技有限公司 A kind of compound rest and preparation method thereof for repair of cartilage
WO2021076798A1 (en) 2019-10-15 2021-04-22 Sofregen Medical, Inc. Delivery devices for delivering and methods of delivering compositions
TWI763265B (en) * 2021-01-20 2022-05-01 巴斯特製藥科技顧問股份有限公司 An organ-repairing membrane with structural proteins and use thereof
CN114354585B (en) * 2021-11-09 2023-09-26 北京航空航天大学 Horseradish peroxidase composite gel photonic crystal sensor and method
CN114505070B (en) * 2022-04-02 2024-02-02 陕西师范大学 Porous nano-enzyme, porous nano-enzyme crystal, preparation method and application thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0224934A2 (en) * 1985-12-05 1987-06-10 Steven B. Feinstein Contrast agent, process for its preparation and its use for ultrasonic imaging
EP0485210A2 (en) * 1990-11-08 1992-05-13 Otogen Corporation Fibrin/collagen membrane material for biomedical use
US5418222A (en) * 1991-06-14 1995-05-23 Amgen Inc. Multi-layered collagen film compositions for delivery of proteins and methods of using same
WO1997041899A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
US5741670A (en) * 1992-04-10 1998-04-21 The General Hospital Corporation Cartilage matrix protein and methods for use
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
WO1999038546A1 (en) * 1998-01-30 1999-08-05 Advanced Cardiovascular Systems, Inc. Hydrophilic coating for an intracorporeal medical device
WO1999049907A1 (en) * 1998-03-31 1999-10-07 Ppl Therapeutics (Scotland) Ltd. Medical devices treated to discourage blood coagulation
US6004943A (en) * 1995-11-27 1999-12-21 Inst. Of Biomedical Engineering, Chinese Acdmy Of Med. Science Protein-coated medical substrates for local delivery of genes and method of forming coatings on the substrates
WO2001019305A1 (en) * 1999-09-13 2001-03-22 Keraplast Technologies Ltd. Water absorbent keratin and gel formed therefrom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0717761A4 (en) * 1993-08-19 1998-01-07 Cygnus Therapeutic Systems Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
JP4332660B2 (en) * 1999-10-01 2009-09-16 Ｏｃｉ株式会社 Mouth cool film

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0224934A2 (en) * 1985-12-05 1987-06-10 Steven B. Feinstein Contrast agent, process for its preparation and its use for ultrasonic imaging
EP0485210A2 (en) * 1990-11-08 1992-05-13 Otogen Corporation Fibrin/collagen membrane material for biomedical use
US5418222A (en) * 1991-06-14 1995-05-23 Amgen Inc. Multi-layered collagen film compositions for delivery of proteins and methods of using same
US5741670A (en) * 1992-04-10 1998-04-21 The General Hospital Corporation Cartilage matrix protein and methods for use
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
US6004943A (en) * 1995-11-27 1999-12-21 Inst. Of Biomedical Engineering, Chinese Acdmy Of Med. Science Protein-coated medical substrates for local delivery of genes and method of forming coatings on the substrates
WO1997041899A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
WO1999038546A1 (en) * 1998-01-30 1999-08-05 Advanced Cardiovascular Systems, Inc. Hydrophilic coating for an intracorporeal medical device
WO1999049907A1 (en) * 1998-03-31 1999-10-07 Ppl Therapeutics (Scotland) Ltd. Medical devices treated to discourage blood coagulation
WO2001019305A1 (en) * 1999-09-13 2001-03-22 Keraplast Technologies Ltd. Water absorbent keratin and gel formed therefrom

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ANDERSON J P ET AL: "MORPHOLOGY AND PRIMARY CRYSTAL STRUCTURE OF A SILK-LIKE PROTEIN POLYMER SYNTHESIZED BY GENETICALLY ENGINEERED ESCHERICHIA COLI BACTERIA", BIOPOLYMERS, NEW YORK, NY, US, vol. 34, no. 8, 1 August 1994 (1994-08-01), pages 1049 - 1058, XP000654875, ISSN: 0006-3525 *
BRADLEY W G ET AL: "Some mechanical property considerations of reconstituted collagen for drug release supports.", BIOMATERIALS, MEDICAL DEVICES, AND ARTIFICIAL ORGANS. 1977, vol. 5, no. 2, 1977, pages 159 - 175, XP009073862, ISSN: 0090-5488 *
CAPPELLO J ET AL: "GENETIC ENGINEERING OF STRUCTURAL PROTEIN POLYMERS", BIOTECHNOLOGY PROGRESS, vol. 6, no. 3, 1 May 1990 (1990-05-01), pages 198 - 202, XP000654980, ISSN: 8756-7938 *
CAPPELLO J ET AL: "In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 53, no. 1-3, 30 April 1998 (1998-04-30), pages 105 - 117, XP004121261, ISSN: 0168-3659 *
CAPPELLO J: "THE BIOLOGICAL PRODUCTION OF PROTEIN POLYMERS AND THEIR USE", TRENDS IN BIOTECHNOLOGY, ELSEVIER, AMSTERDAM,, GB, vol. 8, no. 11, 1 November 1990 (1990-11-01), pages 309 - 311, XP000654874, ISSN: 0167-7799 *
FERRARI F A ET AL: "BIOSYNTHESIS OF PROTEIN POLYMERS", PROTEIN-BASED MATERIALS, 1997, pages 37 - 60, XP009026639 *
FOSCOLO J ET AL: "Full length article", BIOFUTUR. LE MENSUEL EUROPEEN DE BIOTECHNOLOGY, LAVOISIER, CACHAN, FR, vol. 1997, no. 171, October 1997 (1997-10-01), pages 14 - 17, XP004279976, ISSN: 0294-3506 *
See also references of WO0187267A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108310455A (en) * 2018-03-20 2018-07-24 嘉兴尔云信息科技有限公司 Nanometer hydroxyapatite, phosphorylation polyester composite bone repairing material and preparation method thereof

Also Published As

Publication number Publication date
WO2001087267A1 (en) 2001-11-22
JP2003533468A (en) 2003-11-11
AU4907901A (en) 2001-11-26
CA2401385A1 (en) 2001-11-22
AU2001249079B2 (en) 2005-11-03
EP1259223A1 (en) 2002-11-27
CA2401385C (en) 2011-05-17

Similar Documents

Publication Publication Date Title
AU4907901A (en) Protein matrix materials, devices and methods of making and using thereof
EP1435911A4 (en) Devices including protein matrix materials and methods of making and using same
IL153970A0 (en) Promyostatin peptides and methods of using same
IL152725A0 (en) Human receptor proteins, related reagents and methods
EP1293568A4 (en) Novel protein and dna thereof
EP1194548A4 (en) Novel pyrrhocoricin-derived peptides, and methods of use thereof
EP1263935A4 (en) Scytonemin and methods of using thereof
AU2002241570A1 (en) Human proteins, polynucleotides encoding them and methods of using the same
IL153740A0 (en) Grf2-binding proteins and applications thereof
EP1293510A4 (en) Novel polypeptide and its dna
AUPQ645700A0 (en) Novel polypeptides and polynucleotides and methods of using them
AU2000280019A1 (en) Polypeptides, methods of making, and uses thereof
AU2002247052A1 (en) Devices including protein matrix materials and methods of making and using same
AU2002245158A1 (en) Human proteins 55562 and 21617, and methods of use thereof
AU2002214598A1 (en) Claspin proteins and methods of use thereof
EP1428877A4 (en) Novel protein and dna thereof
AU9227301A (en) Novel proteins, genes encoding them and method of using the same
AU2001273447A1 (en) Tetraspan protein and uses thereof
GB0403414D0 (en) Four human zinc-finger-containing proteins:MDZ3,MDZ4,MDZ7 and MDZ12
GB0002559D0 (en) Virulencegene and protein and their use
AU2002215208A1 (en) Novel protein and dna thereof
GB0019503D0 (en) Proteins and their uses
AU2001259109A1 (en) Human proteins, polynucleotides encoding them and methods of using the same
GB0003729D0 (en) Virulene gene and protein, and their use
AU9664901A (en) Novel human proteins, polynucleotides encoding them and methods of using the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020829

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20061030

17Q First examination report despatched

Effective date: 20070911

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20151001